Health ❯Healthcare

Obesity Treatment

Obesity Treatment Pharmaceuticals Drug Development Consumer Demand Safety Protocols Company Stocks Medications Diabetes Market Trends Patient Safety

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Novo Nordisk and Cigna introduce temporary discounts and copay caps as compounded semaglutide distribution ceases under new FDA regulations.

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

UK Tightens Rules for Online Prescriptions of Weight-Loss Drugs